Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can meditation help Parkinson's patients? small study tests feasibility

NCT ID NCT05180643

First seen Jun 06, 2026 · Last updated Jun 23, 2026 · Updated 4 times

Summary

This study looked at whether a structured 8-week mindfulness-based stress reduction (MBSR) program is practical for people with Parkinson's disease. Thirty-one participants were enrolled to see how many could complete the program, including weekly group sessions and a full meditation day. The goal was not to measure health improvements, but to find out if such a program is feasible and what barriers patients face.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • François TISON, M.D PhD

    Bordeaux, 33000, France

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Mindfulness-Based Stress Reduction (MBSR) program

What this could lead to

If successful, this could show that MBSR is a practical, non-drug option to help manage stress and improve quality of life for people with Parkinson's.

What could go wrong

This is a very small, early feasibility study with only 31 participants. It does not measure whether MBSR actually improves symptoms, so results may not lead to clear benefits.

Conditions

The condition(s) this trial relates to.

Parkinson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.